Cargando…

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine

A 38-year-old male and a 36-year-old female experienced red-brown urine discolouration after 2 and 3 days, respectively, during the use of mesalamine for inflammatory bowel disease. Both patients mentioned that the urine discoloured after contact with sodium hypochlorite detergent in toilet water. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeets, Tim, van Hunsel, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005790/
https://www.ncbi.nlm.nih.gov/pubmed/27747686
http://dx.doi.org/10.1007/s40800-016-0029-5
_version_ 1782450972675538944
author Smeets, Tim
van Hunsel, Florence
author_facet Smeets, Tim
van Hunsel, Florence
author_sort Smeets, Tim
collection PubMed
description A 38-year-old male and a 36-year-old female experienced red-brown urine discolouration after 2 and 3 days, respectively, during the use of mesalamine for inflammatory bowel disease. Both patients mentioned that the urine discoloured after contact with sodium hypochlorite detergent in toilet water. Mesalamine and the inactive metabolite N-acetyl-5-aminosalicylic acid are primarily excreted in the urine. We hypothesised a possible reaction with sodium hypochlorite and/or light. Naranjo assessment scores of 9 and 6 were obtained for the reports, indicating a certain and probable relationship, respectively, between the red-brown urine discolouration and the use of the suspect drug mesalamine. Knowledge of this harmless reaction is desirable to avoid unnecessary physical examination and worry.
format Online
Article
Text
id pubmed-5005790
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-50057902016-08-31 Red-Brown Urine Discolouration in Two Patients Taking Mesalamine Smeets, Tim van Hunsel, Florence Drug Saf Case Rep Case Report A 38-year-old male and a 36-year-old female experienced red-brown urine discolouration after 2 and 3 days, respectively, during the use of mesalamine for inflammatory bowel disease. Both patients mentioned that the urine discoloured after contact with sodium hypochlorite detergent in toilet water. Mesalamine and the inactive metabolite N-acetyl-5-aminosalicylic acid are primarily excreted in the urine. We hypothesised a possible reaction with sodium hypochlorite and/or light. Naranjo assessment scores of 9 and 6 were obtained for the reports, indicating a certain and probable relationship, respectively, between the red-brown urine discolouration and the use of the suspect drug mesalamine. Knowledge of this harmless reaction is desirable to avoid unnecessary physical examination and worry. Springer International Publishing 2016-05-12 /pmc/articles/PMC5005790/ /pubmed/27747686 http://dx.doi.org/10.1007/s40800-016-0029-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Smeets, Tim
van Hunsel, Florence
Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
title Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
title_full Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
title_fullStr Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
title_full_unstemmed Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
title_short Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
title_sort red-brown urine discolouration in two patients taking mesalamine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005790/
https://www.ncbi.nlm.nih.gov/pubmed/27747686
http://dx.doi.org/10.1007/s40800-016-0029-5
work_keys_str_mv AT smeetstim redbrownurinediscolourationintwopatientstakingmesalamine
AT vanhunselflorence redbrownurinediscolourationintwopatientstakingmesalamine